Neurodegenerative Diseases: Diagnostic Advancements

This series of cases is designed for healthcare professionals seeking to enhance their understanding of the assessment and treatment options for patients with neurodegenerative diseases. Laboratory testing plays a crucial role in evaluating these conditions, but accurately diagnosing the disease and determining the best treatment options can be challenging. Fortunately, Amprion, in collaboration with Mayo Clinic Laboratories, offers testing to detect alpha-synuclein pathology—potentially years before clinical symptoms emerge. These cases will provide you with the knowledge needed to ensure appropriate testing for patients and empower you to make well-informed clinical decisions.

Questions?

Contact us: mcleducation@mayo.edu

MCL Education

This post was developed by our Education and Technical Publications Team.